This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Anurag Khetan
Site Director, Biologics Process Development at Bristol-Myers Squibb


Anurag Khetan heads the Early Biologics Process Development department of Bristol-Myers Squibb based in NJ.  His team interfaces with Discovery and carries out process development of biologics and viral gene therapy programs ranging from molecular biology, cell line development, upstream and downstream development, and associated process analytics. Anurag has a PhD in Biochemical Engineering from the Hu group at the University of Minnesota. Anurag has had sustained contributions over nearly two decades in the industry ranging from early and late process development, post-approval development, manufacturing support, and GMP manufacturing at Merck, Biogen, Boehringer Ingelheim and BMS.

Agenda Sessions

  • Panel Discussion: Integrating New Engineering and Cell Line Development Technologies into Established Workflows

  • Advances In Cell Line Development And Process Development To Speed Mab And Non Mab Assets Faster To Clinic